SPIA
KERX

Steward Partners Investment Advisory’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Steward Partners Investment Advisory’s Portfolio KERX Stock Details KERX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-300
Closed -$2K – 2000
2017
Q3 		$2K Hold
300
– – ﹤0.01% 1556
2017
Q2 		$2K Hold
300
– – ﹤0.01% 1475
2017
Q1 		$1K Hold
300
– – ﹤0.01% 1472
2016
Q4 		$1K Buy
+300
New +$1.64K ﹤0.01% 851

Other funds holding KERX

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CLM
ClearBridge LLC (Maryland) Baltimore, Maryland $329M AUM 9.73% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Steward Partners Investment Advisory's KERX Position: Q4 2017 in Review

Steward Partners Investment Advisory sold out of Keryx Biopharmaceuticals Inc (KERX) in Q4 2017, closing a stake of 300 shares — an estimated $2K sold.

Steward Partners Investment Advisory first reported a position in KERX in Q4 2016 and held it in 4 quarters. The position peaked at $2K in Q3 2017. 129 funds tracked by Wall St. Rank hold KERX as of Q4 2017.

  • Steward Partners Investment Advisory reported no remaining Keryx Biopharmaceuticals Inc position as of Q4 2017 after selling out during the quarter.
  • Steward Partners Investment Advisory sold 300 Keryx Biopharmaceuticals Inc shares in Q4 2017, an estimated $2K.
  • Steward Partners Investment Advisory first reported a position in Keryx Biopharmaceuticals Inc in Q4 2016 and held it in 4 quarters.
  • Steward Partners Investment Advisory's Keryx Biopharmaceuticals Inc position peaked at $2K in Q3 2017.
  • 129 funds tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q4 2017.

Based on Steward Partners Investment Advisory's 13F filing for Q4 2017, filed 19 Jan 2018.